Search for: "Rachel Sachs" Results 81 - 100 of 126
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
What can policymakers learn from the UK’s RECOVERY trial to improve clinical research for COVID-19 and beyond?
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What administrative actions might we expect on COVID-19 in President-elect Biden’s administration?
30 Nov 2020, 7:24 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How does pregnancy factor into COVID-19 innovation?
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What did we learn from last week’s FDA vaccine advisory committee meeting?
30 Oct 2020, 12:50 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How does the CDC’s Advisory Committee on Immunization Practices impact innovation and access to COVID-19 vaccines?
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can Congress create infrastructure for the next pandemic?
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Week in Review
24 Sep 2020, 9:05 pm by Joshua Burd
In an article in the Yale Journal on Regulation, Rachel Sachs, a professor at Washington University in St. [read post]
RegBlog - http://www.regblog.org/
Friday round-up
6 Mar 2015, 7:18 am by Amy Howe
”  At Harvard’s Bill of Health Blog, Rachel Sachs notes that “the Court displayed a more sophisticated understanding of the consequences of a decision striking down the subsidies in states that have not established their own exchanges. [read post]
SCOTUSblog - http://www.scotusblog.com/
SEC Unveils Controversial ESG Disclosure Rule Proposal
12 Mar 2023, 2:05 pm by Race to the Bottom
The proposal has supporters in the private industry, as well; Rachel Glaser, CFO at Etsy, sees the rule as a step toward creating unified and organized policies and guidance for corporate climate disclosures. [read post]
The Race to the Bottom - https://www.theracetothebottom.org/rttb
Weekly Roundup: June 21–27, 2019
28 Jun 2019, 6:07 am
Securities and Exchange Commission, on Friday, June 21, 2019 Tags: Capital requirements, CFTC, Derivatives, Dodd-Frank Act, Margin requirements, SEC, SEC rulemaking, Securities regulation, Swaps, Swaps entities Rent-A-Center: A $1.37 BN Reminder on Reminders Posted by Rachel Fridhandler, Sidley Austin LLP, on Saturday, June 22, 2019 Tags: Acquisition agreements, Delaware cases, Delaware law, Merger… [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Posthumous Justice for Lawyers
9 May 2014, 2:14 pm
Chang’s descendants remain in the San Francisco Bay Area, including grandniece Rachelle Chong, the first Asian American to serve as a commissioner of the Federal Communications Commission and of the California Public Utilities Commission. [read post]
Ratio Juris - http://ratiojuris.blogspot.com/
How are COVID-19 vaccine manufacturers aiming to encourage trust in the FDA’s approval process?
2 Oct 2020, 7:10 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers encourage the expansion of at-home diagnostic testing for COVID-19?
2 Jun 2020, 10:31 pm by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Are COVID-19 vaccine advance purchases a form of vaccine nationalism, an effective spur to innovation, or something in between?
5 Aug 2020, 11:43 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What does it mean that Oracle is partnering with the Trump administration to study unproven COVID-19 drugs?
30 Mar 2020, 8:40 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOne of the dizzying stream of innovation and health law stories to emerge last week is Oracle’s partnership with the White House to study unproven pharmaceuticals for treating COVID-19. [read post]
Written Description - http://writtendescription.blogspot.com/
What’s happening with proposals for a WTO waiver of COVID-related IP?
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How is the NIH seeking to encourage investment in diagnostic testing for COVID-19?
13 Aug 2020, 8:09 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What can policymakers learn from the disastrously slow COVID-19 vaccine rollout?
12 Jan 2021, 9:04 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How will the FDA’s new COVID-19 vaccine guidance affect development efforts?
10 Jul 2020, 8:59 am by Lisa Larrimore Ouellette
By Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/